GlassScriptPhysician profile
Barry Flippo
NPI 1659844595
$12,743.77
in general payments reported to CMS, 2019-2025
31 companies · $2,570 in 2025
The $2,570 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,288 · 2022: $3,052 · 2023: $2,361 · 2024: $2,473 · 2025: $2,570.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,046 · Education: $357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,046.14 |
| Education | $357.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,850.38 | 2021-2025 | |
| Janssen Biotech, INC. | $1,589.78 | 2021-2025 | Tremfya, Stelara, Simponi Aria |
| Genzyme Corporation | $1,116.79 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $943.79 | 2021-2025 | Ilumya, Winlevi |
| Incyte Corporation | $810.17 | 2021-2025 | Opzelura |
| Novartis Pharmaceuticals Corporation | $796.97 | 2021-2025 | |
| Lilly USA, LLC | $735.13 | 2021-2025 | Taltz, Ebglyss, Olumiant |
| Regeneron Healthcare Solutions, INC. | $720.88 | 2021-2025 | Dupixent |
| Leo Pharma INC. | $649.56 | 2021-2025 | Adbry, Anzupgo |
| Pfizer INC. | $496.03 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $366.73 | 2022-2025 | Sotyktu |
| Ucb, INC. | $287.78 | 2021-2025 | Bimzelx |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $287.23 | 2021-2024 | Cabtreo, Jublia, Arazlo |
| Dermavant Sciences, INC. | $200.30 | 2023-2024 | Vtama |
| Galderma Laboratories, L.P. | $121.92 | 2021-2025 | Nemluvio, Epsolay, Twyneo |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $96.49 | 2022-2025 | Otezla, Otezla |
| Organogenesis INC. | $88.32 | 2025 | Affinity, Puraply Wound Matrix, Simplimax |
| Arcutis Biotherapeutics, INC. | $86.80 | 2024-2025 | Zoryve |
| Journey Medical Corporation | $85.90 | 2022-2023 | |
| Almirall LLC | $76.29 | 2022-2024 | Klisyri, Seysara |
| Vyne Pharmaceuticals INC. | $49.05 | 2021 | |
| Dermira, INC. | $46.24 | 2021 | |
| Mayne Pharma Commercial LLC | $43.31 | 2022 | |
| Biowound Solutions, INC. | $35.74 | 2024 | Bio-Connekt |
| Botanix Sb INC | $33.90 | 2025 | Sofdra |
| Nabriva Therapeutics, Plc | $33.65 | 2022 | |
| Convatec INC. | $29.14 | 2025 | |
| Medimetriks Pharmaceuticals, INC. | $22.78 | 2022 | |
| Genentech USA, INC. | $20.47 | 2022 | |
| Verrica Pharmaceuticals INC. | $18.06 | 2023 | Ycanth |
| Organon LLC | $4.19 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Flippo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.